Filing Flows › Comparisons › ARWR vs VNDA
Arrowhead Pharmaceuticals vs Vanda Pharmaceuticals: ARWR and VNDA compared
Arrowhead Pharmaceuticals is the larger company: $75.3M of revenue in its latest quarter (Q3 FY26) against $69.8M for Vanda Pharmaceuticals (Q3 2026). Arrowhead Pharmaceuticals is growing faster (+171% against +24% a year earlier). Vanda Pharmaceuticals is more profitable, with an operating margin of -33.7% against -226.0%.
Where the money goes: ARWR and VNDA
Arrowhead Pharmaceuticals (ARWR) · Q3 FY26
Arrowhead Pharmaceuticals, Q3 FY26: revenue $75.3M (+171% year over year), operating margin -226.0%, net loss $179M, operating cash flow −$177M. The chart follows the revenue to costs, profit and cash.
Vanda Pharmaceuticals (VNDA) · Q3 2026
Vanda Pharmaceuticals, Q3 2026: revenue $69.8M (+24% year over year), operating margin -33.7%, net loss $22.6M, operating cash flow −$28.4M. The chart follows the revenue to costs, profit and cash.
| Arrowhead Pharmaceuticals (ARWR) | Vanda Pharmaceuticals (VNDA) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q3 2026 |
| Revenue | $75.3M | $69.8M |
| Revenue growth, Y/Y | +171% | +24% |
| Operating margin | -226.0% | -33.7% |
| Net earnings | −$179M | −$22.6M |
| Net margin | -237.8% | -32.3% |
| Operating cash flow | −$177M | −$28.4M |
Where the revenue comes from
Vanda Pharmaceuticals
- Fanapt®: $38.8M (56%)
- HETLIOZ® net product sales: $21.7M (31%)
- PONVORY® net product sales: $7.7M (11%)
- NEREUSTM: $1.6M (2%)
Questions
Which is bigger, Arrowhead Pharmaceuticals or Vanda Pharmaceuticals?
Arrowhead Pharmaceuticals is the larger company: $75.3M of revenue in its latest quarter (Q3 FY26) against $69.8M for Vanda Pharmaceuticals (Q3 2026).
Is Arrowhead Pharmaceuticals or Vanda Pharmaceuticals growing faster?
Arrowhead Pharmaceuticals is growing faster (+171% against +24% a year earlier).
Which is more profitable, Arrowhead Pharmaceuticals or Vanda Pharmaceuticals?
Vanda Pharmaceuticals is more profitable, with an operating margin of -33.7% against -226.0%.
More: Arrowhead Pharmaceuticals earnings · how Arrowhead Pharmaceuticals makes money · Vanda Pharmaceuticals earnings · how Vanda Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 4, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.